Benefits and applications
benefits
AKITA˛® is the leading technology for controlled inhalation of therapeutics and offers the following benefits pharmaceutical and biotechnology companies when used in clinical trials of inhaled therapeutics:
- Full control over patient's breathing pattern
- High intra thoracic deposition
- Precise, reproducible dosages
- Shorter inhalation times
- Individualization due toSmart Card Technology:
- Best treatment for each patient
- Ensures a reliable and reproducible dosage for different patients
- Allows drug targeting to different lung regions
- Compliance-Analysis possible
Applications
AKITA˛® can be used across a range of indications and is of optimal use in trials with the following parameters:
- Dosing studies in the clinical evaluation of inhaled therapeutics
- Application of high amount of drugs into the human lungs, where e.g. powder inhalers are not appropriate
- Patients inhaling high-price drugs, e.g. antibiotics
- Patients inhaling more than 1 hour per day